Pershing Square May Be Cut to Cusp of Junk by S&P on Valeant

Valeant Analyst: More Bad News to Come

Pershing Square Holdings Ltd., the publicly traded security of Bill Ackman’s activist hedge fund, may have its ratings cut by Standard & Poor’s, after a plunge in Valeant Pharmaceuticals International Inc. eroded its net asset value over the past five months.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.